Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

1(25.0%)

N/A

1(25.0%)

Phase 1

1(25.0%)

Phase 2

1(25.0%)

4Total

Phase 3(1)

N/A(1)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT05752422Not ApplicableUnknown

Transcranial Photobiomodulation for Adult ADHD

Role: lead

NCT01769027Phase 2Withdrawn

Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS

Role: lead

NCT03211221Phase 1Unknown

rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder.

Role: lead

NCT03669315Phase 3Recruiting

Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation

Role: lead

All 4 trials loaded